(Q40678743)

22 September 2017

Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache (English)

1 reference

22 September 2017

0 references

1 reference

1 reference

1 reference

Coppola M

1

1 reference

22 September 2017

Yealy DM

series ordinal

2

1 reference

22 September 2017

Leibold RA

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

Annals of Emergency Medicine

22 September 2017

1 reference

22 September 2017

26

1 reference

22 September 2017

541-546

1 reference

22 September 2017

5

1 reference

Parenteral chlorpromazine treatment of migraine

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Acute pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Addiction Rare in Patients Treated with Narcotics

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Metoclopramide: a review of its pharmacological properties and clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

The efficacy of metoclopramide in the treatment of migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

A comparative trial of three agents in the treatment of acute migraine headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Treatment of migraine with intramuscular chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

A survey of drug-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Neurologic approach to drug-induced movement disorders: a study of 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

Intravenous versus rectal prochlorperazine in the treatment of benign vascular or tension headache: a randomized, prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2895%2970001-3

7 January 2021

10.1016/S0196-0644(95)70001-3

Identifiers

DOI

1 reference

22 September 2017

1 reference